JNJ-64565111 Dose Level 1

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Obesity and Diabetes Mellitus, Type 2

Drug Information

Target Indication

Obesity and Diabetes Mellitus, Type 2

Clinical Trial

Last updated: 5/28/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

JNJ

Johnson & Johnson

Related Pipeline

Pain

Respiratory Syncytial Viruses

Human Immunodeficiency Virus Type 1

Heart Decompensation

Psoriasis

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts